The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Gene Review

LINC00328  -  long intergenic non-protein coding RNA 328

Homo sapiens

Synonyms: NCRNA00328, NCRNA00328-1, NCRNA00328A
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of LOC51152


High impact information on LOC51152


Chemical compound and disease context of LOC51152


Biological context of LOC51152


Anatomical context of LOC51152


Associations of LOC51152 with chemical compounds


Regulatory relationships of LOC51152


Other interactions of LOC51152


Analytical, diagnostic and therapeutic context of LOC51152


  1. Immune response to melanoma extracts in three melanoma-prone families. Vandenbark, A.A., Greene, M.H., Burger, D.R., Vetto, R.M., Reimer, R.R. J. Natl. Cancer Inst. (1979) [Pubmed]
  2. Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy. Estin, C.D., Stevenson, U.S., Plowman, G.D., Hu, S.L., Sridhar, P., Hellström, I., Brown, J.P., Hellström, K.E. Proc. Natl. Acad. Sci. U.S.A. (1988) [Pubmed]
  3. Melanoma antigen A4 is expressed in non-small cell lung cancers and promotes apoptosis. Peikert, T., Specks, U., Farver, C., Erzurum, S.C., Comhair, S.A. Cancer Res. (2006) [Pubmed]
  4. Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines. Wan, Y., Bramson, J., Pilon, A., Zhu, Q., Gauldie, J. Cancer Res. (2000) [Pubmed]
  5. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. de Vries, T.J., Fourkour, A., Wobbes, T., Verkroost, G., Ruiter, D.J., van Muijen, G.N. Cancer Res. (1997) [Pubmed]
  6. Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen. Wang, R.F., Wang, X., Atwood, A.C., Topalian, S.L., Rosenberg, S.A. Science (1999) [Pubmed]
  7. A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma. Moreau-Aubry, A., Le Guiner, S., Labarrière, N., Gesnel, M.C., Jotereau, F., Breathnach, R. J. Exp. Med. (2000) [Pubmed]
  8. Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy. Colella, T.A., Bullock, T.N., Russell, L.B., Mullins, D.W., Overwijk, W.W., Luckey, C.J., Pierce, R.A., Restifo, N.P., Engelhard, V.H. J. Exp. Med. (2000) [Pubmed]
  9. Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells. Pieper, R., Christian, R.E., Gonzales, M.I., Nishimura, M.I., Gupta, G., Settlage, R.E., Shabanowitz, J., Rosenberg, S.A., Hunt, D.F., Topalian, S.L. J. Exp. Med. (1999) [Pubmed]
  10. Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells. Wang, R.F., Wang, X., Rosenberg, S.A. J. Exp. Med. (1999) [Pubmed]
  11. Induction of IgG antibodies directed to a M(r) 31,000 melanoma antigen in patients immunized with vaccinia virus melanoma oncolysates. Berthier-Vergnes, O., Portoukalian, J., Lefthériotis, E., Doré, J.F. Cancer Res. (1994) [Pubmed]
  12. Lack of effect of cyclophosphamide on the immunogenicity of a melanoma antigen vaccine. Oratz, R., Dugan, M., Roses, D.F., Harris, M.N., Speyer, J.L., Hochster, H., Weissman, J., Henn, M., Bystryn, J.C. Cancer Res. (1991) [Pubmed]
  13. Post-translational addition of chondroitin sulfate glycosaminoglycans. Role of N-linked oligosaccharide addition, trimming, and processing. Spiro, R.C., Casteel, H.E., Laufer, D.M., Reisfeld, R.A., Harper, J.R. J. Biol. Chem. (1989) [Pubmed]
  14. A comparative study of the relative sensitivity and specificity of radiolabelled monoclonal antibody and computerised tomography in the detection of sites of disease in human malignant melanoma. Elliott, A.T., MacKie, R.M., Murray, T., Doherty, V.R., Adams, F.G. Br. J. Cancer (1989) [Pubmed]
  15. Effect of bacillus Calmette-Guerin immunotherapy on tumor antigen-induced lymphocyte-stimulated protein synthesis in melanoma patients. Roth, J.A., Golub, S.H., Holmes, E.C., Morton, D.L. Surgery (1975) [Pubmed]
  16. Human transferrin: cDNA characterization and chromosomal localization. Yang, F., Lum, J.B., McGill, J.R., Moore, C.M., Naylor, S.L., van Bragt, P.H., Baldwin, W.D., Bowman, B.H. Proc. Natl. Acad. Sci. U.S.A. (1984) [Pubmed]
  17. Genomic stability and functional activity may be lost in telomerase-transduced human CD8+ T lymphocytes. Schreurs, M.W., Hermsen, M.A., Geltink, R.I., Scholten, K.B., Brink, A.A., Kueter, E.W., Tijssen, M., Meijer, C.J., Ylstra, B., Meijer, G.A., Hooijberg, E. Blood (2005) [Pubmed]
  18. Molecular cytogenetic mapping of the human melanoma antigen (MAGE) gene family to chromosome region Xq27-qter: implications for MAGE immunotherapy. Oaks, M.K., Hanson, J.P., O'Malley, D.P. Cancer Res. (1994) [Pubmed]
  19. The melanoma antigen genes--any clues to their functions in normal tissues? Ohman Forslund , K., Nordqvist, K. Exp. Cell Res. (2001) [Pubmed]
  20. Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage. Lupetti, R., Pisarra, P., Verrecchia, A., Farina, C., Nicolini, G., Anichini, A., Bordignon, C., Sensi, M., Parmiani, G., Traversari, C. J. Exp. Med. (1998) [Pubmed]
  21. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Kawakami, Y., Eliyahu, S., Delgado, C.H., Robbins, P.F., Rivoltini, L., Topalian, S.L., Miki, T., Rosenberg, S.A. Proc. Natl. Acad. Sci. U.S.A. (1994) [Pubmed]
  22. Differential expression of MAGE-1, -2, and -3 messenger RNA in transformed and normal human cell lines. Zakut, R., Topalian, S.L., Kawakami, Y., Mancini, M., Eliyahu, S., Rosenberg, S.A. Cancer Res. (1993) [Pubmed]
  23. Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides. Salgaller, M.L., Afshar, A., Marincola, F.M., Rivoltini, L., Kawakami, Y., Rosenberg, S.A. Cancer Res. (1995) [Pubmed]
  24. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Jang, S.J., Soria, J.C., Wang, L., Hassan, K.A., Morice, R.C., Walsh, G.L., Hong, W.K., Mao, L. Cancer Res. (2001) [Pubmed]
  25. Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen glycoprotein 100. Lapointe, R., Royal, R.E., Reeves, M.E., Altomare, I., Robbins, P.F., Hwu, P. J. Immunol. (2001) [Pubmed]
  26. Human melanocytes and melanomas express novel mRNA isoforms of the tyrosinase-related protein-2/DOPAchrome tautomerase gene: molecular and functional characterization. Pisarra, P., Lupetti, R., Palumbo, A., Napolitano, A., Prota, G., Parmiani, G., Anichini, A., Sensi, M. J. Invest. Dermatol. (2000) [Pubmed]
  27. Large-scale monocyte enrichment coupled with a closed culture system for the generation of human dendritic cells. Pullarkat, V., Lau, R., Lee, S.M., Bender, J.G., Weber, J.S. J. Immunol. Methods (2002) [Pubmed]
  28. Hypertonicity induction of melanoma antigen, a tumor-associated antigen. Park, J.H., Lee, S.W. Mol. Cells (2002) [Pubmed]
  29. Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia. Matsushita, M., Ikeda, H., Kizaki, M., Okamoto, S., Ogasawara, M., Ikeda, Y., Kawakami, Y. Br. J. Haematol. (2001) [Pubmed]
  30. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Steinbrink, K., Jonuleit, H., Müller, G., Schuler, G., Knop, J., Enk, A.H. Blood (1999) [Pubmed]
  31. Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma. Lindsey, K.R., Gritz, L., Sherry, R., Abati, A., Fetsch, P.A., Goldfeder, L.C., Gonzales, M.I., Zinnack, K.A., Rogers-Freezer, L., Haworth, L., Mavroukakis, S.A., White, D.E., Steinberg, S.M., Restifo, N.P., Panicali, D.L., Rosenberg, S.A., Topalian, S.L. Clin. Cancer Res. (2006) [Pubmed]
  32. A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23. Gaugitsch, H.W., Hofer, E., Huber, N.E., Schnabl, E., Baumruker, T. Eur. J. Immunol. (1991) [Pubmed]
  33. Identification of a melanoma antigen, PRAME, as a BCR/ABL-inducible gene. Watari, K., Tojo, A., Nagamura-Inoue, T., Nagamura, F., Takeshita, A., Fukushima, T., Motoji, T., Tani, K., Asano, S. FEBS Lett. (2000) [Pubmed]
  34. New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines. Maeurer, M.J., Storkus, W.J., Kirkwood, J.M., Lotze, M.T. Melanoma Res. (1996) [Pubmed]
  35. Expression of MAGE genes and survival in patients with hepatocellular carcinoma. Suzuki, K., Tsujitani, S., Konishi, I., Yamaguchi, Y., Hirooka, Y., Kaibara, N. Int. J. Oncol. (1999) [Pubmed]
  36. Activation of human melanoma reactive CD8+ T cells by vaccination with an immunogenic peptide analog derived from Melan-A/melanoma antigen recognized by T cells-1. Ayyoub, M., Zippelius, A., Pittet, M.J., Rimoldi, D., Valmori, D., Cerottini, J.C., Romero, P., Lejeune, F., Liénard, D., Speiser, D.E. Clin. Cancer Res. (2003) [Pubmed]
  37. Adoptive transfer of an anti-MART-1(27-35)-specific CD8+ T cell clone leads to immunoselection of human melanoma antigen-loss variants in SCID mice. Lozupone, F., Rivoltini, L., Luciani, F., Venditti, M., Lugini, L., Cova, A., Squarcina, P., Parmiani, G., Belardelli, F., Fais, S. Eur. J. Immunol. (2003) [Pubmed]
  38. Novel melanoma antigen, FCRL/FREB, identified by cDNA profile comparison using DNA chip are immunogenic in multiple melanoma patients. Inozume, T., Matsuzaki, Y., Kurihara, S., Fujita, T., Yamamoto, A., Aburatani, H., Shimada, S., Kawakami, Y. Int. J. Cancer (2005) [Pubmed]
  39. Use of recombinant poxviruses to stimulate anti-melanoma T cell reactivity. Kim, C.J., Cormier, J., Roden, M., Gritz, L., Mazzara, G.P., Fetsch, P., Hijazi, Y., Lee, K.H., Rosenberg, S.A., Marincola, F.M. Ann. Surg. Oncol. (1998) [Pubmed]
  40. Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-1. Kelley, L.C., Starkus, L. J. Am. Acad. Dermatol. (2002) [Pubmed]
WikiGenes - Universities